Kumar et al.
JOCArticle
hydrogen atom transfer. However, improving the antioxidant
activity of phenolic compounds along these lines will be
successful only until the ionization potential of the compounds
(which is also decreased by introduction of electron-donating
groups) becomes so low4 that the material will be consumed in
a spontaneous electron-transfer reaction with molecular oxy-
gen. Recently, by incorporating one or two nitrogens into the
hydroxyaromatic ring, the groups of Pratt and Valgimigli
found a way to circumvent the problem with the low ionization
potential. Thus, whereas the O-H bond dissociation enthal-
pies (BDEs) of substituted 5-pyrimidinols and 3-pyridinols
differed only marginally from those of the corresponding
phenols, the ionization potentials were substantially higher.
The O-H bond of 5-pyrimidinol 1 (78.2 kcal mol-1) has
almost the same strength as that of R-tocopherol (2; 78.3 kcal
mol-1), but the calculated ionization potential is 7.7 kcal
mol-1 higher (167.0 kcal mol-1).5 Furthermore, as judged by
the capacity to inhibit autoxidation of styrene, pyrimidinol 1
(kinh = 8.6 ꢀ 106 M-1 s-1) transfers its phenolic hydrogen
atom to peroxyl radicals almost three times as fast as
R-tocopherol (kinh = 3.2 ꢀ 106 M-1 s-1).4 It has been hypo-
thesized that this rate enhancement is due to polar effects in the
transition state of the atom-transfer reaction.6 Incorporation
of an electron-donating amino substituent para to the hydroxyl
group in the 3-pyridinol scaffold in a fused five-membered ring
(compound 3) resulted in the most effective phenolic chain-
breaking antioxidant reported to date. Its ionization potential
is 7.0 kcal mol-1 lower than calculated for R-tocopherol, and
therefore it slowly decomposes when exposed to atmospheric
oxygen. As a result of the 2.8 kcal mol-1 weaker O-H BDE of
compound 3 compared to that of R-tocopherol, the reactivity
eration to allow for a catalytic mode of action of the antioxidant.
In biological membranes this process is thought to occur by do-
nation of a hydrogen atom from ascorbate (AscH-) to the R-to-
copheroxyl radical at the lipid-aqueous interphase (eq 1).11-14
R-TO• þ AscH- f R-TOH þ Asc• -
ð1Þ
The tripeptide glutathione (GSH) is present in much
higher concentrations than ascorbate in human plasma. It
is known to act as a biological antioxidant and reducing
agent both by one-electron (hydrogen atom) and two-elec-
tron (e.g., as a cofactor for the glutathione peroxidase
enzymes) chemistry. However, early studies by Barclay15
showed that GSH is incapable of regenerating R-tocopherol
from the R-tocopheroxyl radical in simple model systems. In
our search for other chain-breaking antioxidants that could
perform in a catalytic fashion in the presence of thiols, we
recently found that 2,3-dihydrobenzo[b]selenophene-5-ols
516 and ethoxyquins 617 were regenerable by N-acetylcys-
teine when assayed for their capacity to inhibit azo-initiated
peroxidation of linoleic acid in a two-phase system. Con-
sidering that none of these antioxidants quenched peroxyl
radicals as efficiently as R-tocopherol, we thought it would
be interesting to try to modify the efficient pyridinol anti-
oxidants in such a way that they could also act in a catalytic
fashion in the presence of stoichiometric amounts of a thiol
reducing agent. In this paper we report on the synthesis of
3-pyridinols carrying organosulfur organoselenium, and
organotellurium substituents. Their inhibition of autoxida-
tion in a two-phase system and in a purely lipid environment
is described, and a mechanism is proposed for the observed
catalytic mode of action.18
toward peroxyl radicals is an impressive 88-fold higher (kinh
=
280 ꢀ 106 M-1 s-1).7,8 The synthesis and antioxidative proper-
ties of more vitamin E-like derivatives of this kind,9 such as the
naphthyridinol 4, have recently been described.10
Results and Discussion
Synthesis. For introduction of chalcogens into the
3-pyridinol scaffold, it was thought that halogenated deri-
vatives, which are commercially available with some variety,
could serve as suitable starting materials. On treatment with
3 equiv of t-BuLi in dry THF at -78 °C, 6-bromo-3-pyri-
dinol produced a solution of the corresponding 6,O-dili-
thiated species (Scheme 1). For preparation of the octyltel-
luro derivative 7a, it was found most convenient to add finely
ground elemental tellurium to the organolithium and then
allow the insertion product to air-oxidize to the correspond-
ing ditelluride. Subsequent borohydride reduction of crude
ditelluride and alkylation with octyl bromide afforded com-
pound 7a in 66% overall yield. Selenide 7b and sulfide 7c
R-Tocopherol, the most reactive component of vitamin E, is
known to trap two peroxyl radicals before it is converted into
nonradical products. Nature has therefore arranged for its regen-
(11) Halliwell, B.; Gutteridge, J. M. C. Free Radicals in Biology and
Medicine, 4th ed.;Oxford University Press: Oxford, 2007; p 168.
˚
(12) Kamal-Eldin, A.; Appelquist, L.-A. Lipids 1996, 31, 671–701. ; also
see refs 266-286. See also: Sato, K.; Niki, E.; Shimasaki, H. Arch. Biochem.
Biophys. 1990, 279, 402–405. Bisby, R.; Parker, A. W. Arch. Biochem.
Biophys. 1995, 317, 170–178. Noguchi, N.; Niki, E. Free Radical Res. 1998,
28, 561–572. Niki, E.; Noguchi, N. Acc. Chem. Res. 2004, 37, 45–51.
(13) Niki, E.; Saito, T.; Kawakami, A; Kamiya, Y. J. Biol. Chem. 1984,
259, 4177–4182.
(14) Niki, E.; Kawakami, A.; Yamamoto, Y.; Kamiya, Y. Bull. Chem.
Soc. Jpn. 1985, 58, 1971–1975. Doba, T.; Burton, G. W.; Ingold, K. U.
Biochem. Biophys. Acta 1985, 835, 298–303.
(15) Barclay, L. R. C. J. Biol. Chem. 1988, 263, 16138–16142.
(16) Kumar, S.; Johansson, H.; Engman, L.; Valgimigli, L.; Amorati, R.;
Fumo, M. G.; Pedulli, G. F. J. Org. Chem. 2007, 72, 2583–2595.
(17) Kumar, S.; Engman, L.; Valgimigli, L.; Amorati, R.; Fumo, M. G.;
Pedulli, G. F. J. Org. Chem. 2007, 72, 6046–6055.
(4) Burton, G. W.; Doba, T.; Gabe, E. J.; Hughes, L.; Lee, F. L.; Prasad,
L.; Ingold, K. U. J. Am. Chem. Soc. 1985, 107, 7053–7065.
(5) Pratt, D. A.; DiLabio, G. A.; Brigati, G.; Pedulli, G. F.; Valgimigli, L.
J. Am. Chem. Soc. 2001, 123, 4624–4626.
(6) Valgimigli, L.; Brigati, G.; Pedulli, G. F.; DiLabio, G. A.; Mastra-
gostino, M.; Arbizzani, C.; Pratt, D. A. Chem.;Eur. J. 2003, 9, 4997–5010.
(7) Wijtmans, M.; Pratt, D. A.; Valgimigli, L.; DiLabio, G. A.; Pedulli, G.
F.; Porter, N. A. Angew. Chem., Int. Ed. 2003, 42, 4370–4373.
(8) Wijtmans, M.; Pratt, D. A.; Brinkhorst, J.; Serwa, R.; Valgimigli, L.;
Pedulli, G. F.; Porter, N. A. J. Org. Chem. 2004, 69, 9215–9223.
(9) Kim, H.-Y.; Pratt, D. A; Seal, J. R.; Wijtmans, M.; Porter, N. A.
J. Med. Chem. 2005, 48, 6787–6789. Nam, T.; Wijtmans, M.; Pratt, D. A.;
Porter, N. A. Synthesis 2005, 1397–1404.
(10) Nam, T.; Rector, C. L.; Kim, H.; Sonnen, A. F.-P.; Meyer, R.; Nau,
W. M.; Atkinson, J.; Rintoul, J.; Pratt, D. A.; Porter, N. A. J. Am. Chem. Soc.
2007, 129, 10211–10219.
(18) For a preliminary account on this work, see: Kumar, S.; Johansson,
€
H.; Kanda, T.; Engman, L.; Muller, T.; Jonsson, M.; Pedulli, G. F.; Petrucci,
S.; Valgimigli, L. Org. Lett. 2008, 10, 4895–4898.
J. Org. Chem. Vol. 75, No. 3, 2010 717